Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascendant is a biotechnology company focused on the design and development of next-generation biologics using advanced protein engineering and synthetic biology. The company leverages a proprietary platform to create novel proteins and peptides with optimized therapeutic properties, aiming to address unmet needs in various disease areas. By integrating computational design with high-throughput screening, Ascendant seeks to accelerate the discovery of highly specific and potent therapeutic candidates. The company's approach is designed to overcome traditional limitations in biologic drug development, such as stability and manufacturing complexity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ascendant.